Skip to content

Autogenous Bone Block Versus Extended Platelet Rich Fibrin Block for Horizontal Augmentation of Maxillary Ridge With Simultaneous Implant Placement

Autogenous Bone Block Versus Extended Platelet Rich Fibrin Block Used for Horizontal Augmentation of Atrophic Esthetic Zone of Maxillary Ridge Associated With Simultaneous Implant Placement

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07424573
Enrollment
20
Registered
2026-02-20
Start date
2024-05-09
Completion date
2026-04-01
Last updated
2026-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extented Platelet Rich Fibrin Block

Keywords

extented platelet rich fibrin

Brief summary

The aim of the study is directed to assess the clinical and radiographic outcomes of autogenous bone block versus extended PRF block used for horizontal augmentation of atrophied esthetic area of maxillary ridge associated with simultaneous implant placement.

Detailed description

Twenty implants inserted in 16 patients will be randomly and uniformly distributed into two equal groups: Group I: Ten dental implants will be inserted simultaneously in eight patients with horizontal ridge augmentation done by symphyseal onlay autogenous block technique. Group II: Ten dental implants will be inserted simultaneously in nine patients with horizontal ridge augmentation done by onlay extended platelet rich fibrin technique using a mixture of allografts and xenografts.

Interventions

PROCEDUREgroup I: autogenous bone block

Full thichness flap is done and the implant is inserted in place. After that, an autogenous block is harvested from the symphyseal area and fixed in the area of the defect

PROCEDUREextented platelet rich fibrin

Full thickness flap is made and the implant is inserted in place. After that the platelet rich fibrin is collected from the patient blood and heated to produce e-platelet rich fibrin, mixed with a mixture of allograft and xenograft to make e-platelet rich fibrin block placed in the defect area

Sponsors

Naira elnagar
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

quadruple ( participant, care provider, investigator, outcomes assessor)

Intervention model description

Patients will be randomly and uniformly distributed into two equal groups: Group I: Ten dental implants will be inserted simultaneously with horizontal ridge augmentation done by onlay autogenous block technique. Group II: Ten dental implants will be inserted simultaneously with horizontal ridge augmentation done by onlay extended PRF technique using allograft.

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Maxillary narrow ridge in the esthetic anterior zone (about 4-5 mm in width). * Bone height allows the insertion of at least 8 mm of implant length without the need for vertical augmentation. * Patient aged 18-45 years old. * The presence of enough amount of keratinized gingiva as well as enough space for prosthesis rehabilitation. * Favorable occlusion without presence of parafunctional habits. * Cooperative patient with high motivation and acceptable oral hygiene. * Patients are medically free from systemic diseases or drugs that absolutely contraindicate implant surgery. * Patients able to comply with the required recall visits.

Exclusion criteria

* Local and / or systemic conditions that may affect passively the clinical procedure or results. * Heavy smokers(\>20 cigarettes/d).(1) * Alcohol or drug abuse. * Patients with parafunctional habits (bruxism and clenching). * Pregnancy. * Uncooperative patients.

Design outcomes

Primary

MeasureTime frameDescription
bone widthimmediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)The horizontal bone gain resulted from the ridge augmentation was measured at 2,4,6 mm apical to the alveolar crest level, then the mean was calculated. This calculation was done at T0 (BG0), T3 (BG3) and T6 (BG6).

Secondary

MeasureTime frameDescription
marginal bone lossimmediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)On the cross-sectional view, a line was drawn buccally and lingually just parallel to the long axis of the implant, starting at the most cervical bone implant contact to the apex of the implant. Bone height in millimeters was recorded at immediate postsurgical phase after implant insertion. Vertical bone loss was calculated by subtracting recorded marginal bone level value buccally and lingullay after 3 months (at time of implant loading (T3) and after 6 months of implant loading (T6) from immediate postoperative value (T0).
Relative Alveolar Bone Densityimmediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)All density records were collected from the cross-sectional view of CBCT using the Hounsfield unit (HU) according to Misch's classification. ROI tool was used representing the average estimated bone density at 3 mid-buccal levels of the placed implant at T0 (immediately after surgery) and after 3 months (at time of implant loading (T3) and after 6 months of implant loading (T6), in comparison to the primary measures.
Bone volumeimmediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)The volume of the gained bone resulted from the ridge augmentation was measured at T0 (BG0), T3 (BG3) and T6 (BG6).
Postoperative Painon the 1st, 3rd, and 7th days after augmentation surgery\- By using a 10-point Visual Analogue Scale (VAS) for assessment of pain by the patient on the 1st, 3rd, and 7th days after augmentation surgery. (0-1=None, 2-4=Mild, 5-7=Moderate, 8-10=Severe)
Landry Healing Index for Wound Healing Evaluationimmediately at 14th day during suture removal visit, one month and 3 months after surgery.\- The area of operation was examined by using healing index by Landry et al., this index scores clinical signs and symptoms of infection as redness, hotness, pus discharge, bleeding and pain. In addition to that, any manifestations of wound healing disturbance including wound dehiscence and exposure of underlying bone graft were recorded carefully.
Modified sulcus bleeding Index (mSBI)It was recorded immediately after implant loading and after 6 months of loading.Clinical signs and symptoms of inflammation of peri-implant mucosa were graded using criteria of mSBI. It was recorded immediately after implant loading and after 6 months of loading at four aspects around the implants; buccal, lingual, mesial, and distal. The four readings were averaged and approximated to nearest 0.5.
Peri-implant pocket depth (PPD)immediately after implant loading and after 6 months of loadingDepth of the peri-implant sulcus was recorded immediately after implant loading and after 6 months of loading. The distance between the gingival margin and the base of the pocket was recorded using a graduated periodontal probe with light force to avoid undue tissue damage and over-extension into the healthy tissue. The probe was inserted buccally, mesially, lingually and distally around each implant in a line parallel to the implant vertical axis until the blunt end of the probe reached the base of the pocket. The four readings were averaged and approximated to nearest 0.5mm.
bone areaimmediately after augmentation and implant placement (T0), and after 3 months (at time of implant loading) (T3) and after six months from implant loading (T6) (totally, 9 months follow up)The horizontal bone gain area resulted from the ridge augmentation was measured at T0 (BG0), T3 (BG3) and T6 (BG6).
Measurement of implant stabilityimmediately after the placement (T0) and after three months at time of implant loading (T3), then after six months from implant loading (T6).The primary Implant Stability Quotient (ISQ) was measured by using a resonance frequency analyzer (Osstell device) immediately after the placement (T0) and after three months at time of implant loading (T3), then after six months from implant loading (T6). RFA technology depends on fork tuning principle. A Smart Peg was attached to the implant and torqued to 10 Ncm and then the peg was made to vibrate just like a tuning fork by the Osstell device. The purpose here was to find the resonance frequency with the strongest vibration.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026